Select Publications
Journal articles
1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42
,1977, 'The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells', Agents and Actions, 7, pp. 431 - 436, http://dx.doi.org/10.1007/BF01966848
,1977, 'Magnetic anomalies in ErFe
1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410
,1977, 'Salicylates in rheumatoid arthritis: Pharmacokinetics and analgesic responses', Agents and Actions, 7, pp. 35 - 42
,1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 213
,1977, 'The effect of enteric coating of aspirin tablets on occult gastrointestinal blood loss', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214 - 215
,1977, 'The effect of non steroidal anti inflammatory drugs on ATP levels and histamine release from rat peritoneal cell suspension rich in mast cells', Clinical and Experimental Pharmacology and Physiology, 4, pp. 212 - 213
,1977, 'THE EFFECT OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', British Journal of Pharmacology, 59, pp. 29 - 33, http://dx.doi.org/10.1111/j.1476-5381.1977.tb06973.x
,1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x
,1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214
,1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x
,1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, 1, pp. 617 - 619, http://dx.doi.org/10.5694/j.1326-5377.1976.tb140908.x
,1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, 2, pp. 442
,1975, 'Salicylates in Rheumatoid Arthritis', Clinics in Rheumatic Diseases, 1, pp. 245 - 265, http://dx.doi.org/10.1016/s0307-742x(21)00120-x
,Conference Papers
2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'DO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS CAUSE OSTEOARTHRITIS PROGRESSION, A SYSTEMATIC REVIEW AND META ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, CANADA, Toronto, pp. S280 - S282, presented at OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, CANADA, Toronto, 02 May 2019 - 05 May 2019, http://dx.doi.org/10.1016/j.joca.2019.02.663
,2016, 'EFFICACY OF SCALP COOLING AND PHARMACOKINETICS AT THE KINGHORN CANCER CENTRE, ST VINCENT'S HOSPITAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'The impact of ribavirin plasma concentration on the eficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 127 - 132, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP2984
,2013, 'Identification of strategies to reduce computerized alerts in an electronic prescribing system using a Delphi approach', in Lehmann CU; Ammenwerth E; Nøhr C (eds.), IOS Press, Amsterdam, pp. 8 - 12, http://dx.doi.org/10.3233/978-1-61499-289-9-8
,2012, 'Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes', Dunedin, New Zealand, presented at New Zealand Bioethics Conference, Dunedin, New Zealand
,2011, 'The effectiveness of two commercial prescribing systems to reduce medication errors in hospital', Melbourne, Australia, presented at Annual Conference of the Australasian Association for Quality in Health Care (AAQHC), Melbourne, Australia, 12 October 2011 - 14 October 2011
,2011, 'Ethnographic observation as a method of investigating alert fatigue', in Proceedings of the 5th International Symposium on Human Factors Engineering in Health Informatics, Tapir Academic Press, Trondheim, Norway, pp. 71 - 76, presented at 5th Human factors engineering, Trondheim, Norway, 26 August 2011 - 27 August 2011
,2010, 'THE IMPACT OF COMPUTERISED DECISION SUPPORT ON SELECTING MEDICINES FOR PRESCRIPTION', Melbourne, Australia, presented at ASCEPT Annual Scientific meeting, Melbourne, Australia, 28 November 2010 - 01 December 2010
,2010, 'The effectiveness of an electronic medication management system to reduce prescribing errors in hospital', in 18th Annual Health Informatics Conference, Health Informatics Society of Australia, Mebourne, pp. 1 - 8, presented at HIC 2010, 18th National Health Informatics Conference, Melbourne, Australia, 24 August 2010 - 26 August 2010, http://search.informit.com.au/documentSummary;dn=430012692310760;res=IELHEA
,2009, 'Measurement of Oxypurinol Concentrations in Urine by HPLC-Tandem Mass Spectrometry', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Montreal, pp. 640 - 640, presented at 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, CANADA, Montreal, 03 October 2009 - 08 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270484600142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'ChemPrep: Self-paced owl preparation for general chemistry and organic chemistry', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Diego, pp. U346 - U346, presented at 229th National Meeting of the American-Chemical-Society, CA, San Diego, 13 March 2005 - 17 March 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000228177702047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'Extended multi-objective fast messy genetic algorithm solving deception problems', in Coello CAC; Aguirre AH; Zitzler E (eds.), EVOLUTIONARY MULTI-CRITERION OPTIMIZATION, SPRINGER-VERLAG BERLIN, MEXICO, Guanajuato, pp. 296 - 310, presented at 3rd International Conference on Evolutionary Multi-Criterion Optimization (EMO 2005), MEXICO, Guanajuato, 09 March 2005 - 11 March 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229021300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2001, 'A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis', in Journal of Rheumatology, pp. 1170 - 1173
,2000, 'Cox 2 Inhibitors and safety', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Newcastle, pp. 1.12, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle
,2000, 'Fewer Gastrointestinal Protective Agents, Procedures & Hospitalisations with Rofecoxib vs. Naproxen in the Vigor (VIOXXX GI Outcomes Research) Study', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Newcastle, pp. 6.35, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle
,1999, 'Drug interactions with methadone: Pharmacokinetics', in Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, presented at Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, 28 January 1999 - 29 January 1999
,1998, 'Describing the performance of pharmacy and therapeutics committees', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 179, presented at Clinical and Pharmacology Therapeutics
,1998, 'Non steroidal anti-inflammatory drugs (NSAIDS) in rheumatoid and osteoarthritis: support for the concept of `responders` and `non-responders`', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 15, presented at Archives of Pharmacology 358, Munich, Germany
,1997, 'THERAPEUTIC CONSIDERATIONS FROM PHARMACOKINETICS AND METABOLISM: IBUPROFEN AND PARACETAMOL.', in Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, presented at Safety and Efficacy of non-prescription analgesics and NSAIDS, San Francisco, California USA, 17 March 1997 -
,Conference Posters
2015, 'Potentially inappropriate medications (PIMS) in older hospital in-patients: prevalence at admission and discharge, and contribution to hospital admission', Vol. 34, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354463000124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014
,2013, 'USE OF A POPULATION PHARMACOKINETIC MODEL TO PREDICT WEEK 4 RIBAVIRIN LEVELS FROM EARLY CONCENTRATIONS', NETHERLANDS, Amsterdam, Vol. 58, pp. S357 - S357, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)60872-7
,1990, 'A human model for evaluation of non-steroidal anti-inflammatory drug (NSAID) distribution into extracellular fluid', Vol. 183, pp. 1034, http://dx.doi.org/10.1016/0014-2999(90)92891-L
,1990, 'Validation of a human model of experimental pain for testing pharmacodynamics of non-steroidal anti-inflammatory drugs', Vol. 183, pp. 1036, http://dx.doi.org/10.1016/0014-2999(90)92893-N
,Conference Presentations
2014, 'ASSOCIATION OF THE TOLL-LIKE RECEPTOR 4 (TLR4) GENE WITH GOUT', presented at 15th Annual European Congress of Rheumatology (EULAR), FRANCE, Paris, 11 June 2014 - 14 June 2014, http://dx.doi.org/10.1136/annrheumdis-2014-eular.4781
,2013, 'SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1983, 'DETERMINATION OF RESPONSE OF INDIVIDUAL PATIENTS WITH RHEUMATOID-ARTHRITIS TO AURANOFIN', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1982, 'CHLORAMBUCIL IN RHEUMATOID-ARTHRITIS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1977, 'Bioavailability, gastrointestinal microbleeding and side effects of four aspirin formulations in subjects with rheumatoid arthritis'
,1977, 'INFLUENCE OF CORTICOSTEROIDS ON METABOLISM AND PLASMA CONCENTRATIONS OF SALICYLATE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1977, 'MAST-CELLS, INFLAMMATION AND ANTI-INFLAMMATORY DRUGS', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,